Answer
Bulevirtide acetate (Hepcludex) is indicated for chronic hepatitis D in adults and children aged 3 years and older weighing at least 10 kg who are plasma (or serum) HDV-RNA positive and have compensated liver disease.
Sources for this answer
- HEPCLUDEX 2 mg powder for solution for injectionGilead Sciences Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 8Document updated
Sources checked